Multiple Sclerosis and the Division of Neuro-immunology
Under the guidance of world-renowned MS clinician-scientist, Dr. Daniel Pelletier, Division Chief of Neuro-Immunology, the Yale Multiple Sclerosis Center provides state-of-the-art treatment for patients with MS and related diseases, and engages in basic research and clinical trials to advance both the understanding of the disorder and continually improve treatment options. The Yale MS Center is focused on patient care and research, with cutting edge clinical trials and laboratory research in collaboration with the division of Human Translational Immunology in the Department of Immunobiology, the Magnetic Resonance Research Center in the Department of Diagnostic Radiology, and Computational Biology and Genetics. The multidisciplinary program has numerous clinical trials in progress with highly experienced personnel, including specially trained physicians, and nurses. The Yale Neuroimaging Center provides advanced imaging and MRI scanners for MS patients. The Center has participated in pivotal trials in many of the currently approved drugs for MS, including glatiramer acetate (Copaxone®), interferons including Avonex®, mitoxantrone (Novantrone®), and natalizumab (Tysabri®), as well as the recently approved oral disease modifying therapy, fingolimod (Gilenya®) and BG-12 (Tecfidera®).
Members of the Yale MS Center
- Daniel Pelletier, MD, Division Chief, Associate Professor
- David A. Hafler, MD, Chairman and Professor, Department of Neurology
- Christina Azevedo, MD, Assistant Professor
- Mary Bailey, MD, Assistant Professor
- David Pitt, MD, Assistant Professor
- Christoph Juchem, PhD, Assistant Professor
- Diana Ricitelli, APRN
- Kristi Dondlinger, Registered Nurse
- Aracely Delgadillo, Clinical Research Coordinator
- Evangelia Louizos, Clinical Research Coordinator
- Joan Nye, Clinical Research Coordinator
To schedule an appointment or make a referral to one of our neuro-immunology specialists, please call (203) 287-6100 or send a fax to (203) 287-6101.